Rasi Bhadramani/iStock through Getty Photographs
The U.S. FDA stated on Monday that it recommends lifting the voluntary maintain on Sarepta Therapuetics’ gene remedy, Elevidys, in ambulatory sufferers.
Final Friday, the FDA stated that it’ll examine the loss of life of an 8-year-old boy who acquired Elevidys, a remedy
